CAS RN: 161552-03-0

CYCLO (ARG-GLY-ASP-D-PHE-LYS)

Product Availability

Choose a grade to view its available package options.

9 package records8 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20260311 10mg In stock Shanghai, Shandong, Hebei Inquiry
Batchno.20251129 250mg Out of stock 5-7 business days Inquiry
Batchno.20250206 50mg In stock Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250228 100mg In stock Shanghai, Shenzhen Inquiry
Batchno.20250916 10mg In stock Shanghai Inquiry
Batchno.20260611 1g In stock Shanghai Inquiry
Batchno.20250108 250mg In stock Shanghai Inquiry
Batchno.20250821 25mg In stock Shanghai Inquiry
Batchno.20250419 50mg In stock Shanghai, Tianjin Inquiry
  • Product code: starshine_CAS161552-03-0
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

161552-03-0 / 2-[(2S,5R,8S,11S)-8-(4-aminobutyl)-5-benzyl-11-[3-(diaminomethylideneamino)propyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid

Standard CAS: 161552-03-0 Multi CAS: No

Basic Information

CAS
161552-03-0
Multi CAS
No
Molecular Formula
C27H41N9O7
Molecular Weight
603.700000
Exact Mass
603.312895
SMILES
C1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCN=C(N)N)CCCCN)CC2=CC=CC=C2)CC(=O)O
InChI
InChI=1S/C27H41N9O7/c28-11-5-4-9-18-24(41)34-17(10-6-12-31-27(29)30)23(40)32-15-21(37)33-20(14-22(38)39)26(43)36-19(25(42)35-18)13-16-7-2-1-3-8-16/h1-3,7-8,17-20H,4-6,9-15,28H2,(H,32,40)(H,33,37)(H,34,41)(H,35,42)(H,36,43)(H,38,39)(H4,29,30,31)/t17-,18-,19+,20-/m0/s1
InChIKey
NVHPXYIRNJFKTE-HAGHYFMRSA-N

Computed Properties

Structural Parameters

Heavy atom count
43
Aromatic heavy atom count
6
Fraction Csp3
0.52
Rotatable bonds
12
H-bond acceptors
8
H-bond donors
9
Molar refractivity
155.95
TPSA
273.22

LogP / Solubility

WLOGP
-3.04
MLOGP
-2.63
XLogP3
-4.7
Consensus LogP
-3.46
Log S (ESOL)
-0.98
Class (ESOL)
Very soluble
Log S (Ali)
-2.31
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-2.5
Class (SILICOS-IT)
Moderately soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-8.56

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
7.5

Get In Touch

Contact Us